Source: BioPortfolio

PSG: Pharmaceutical Strategies Group Unveils 340B Product Rebranding

Pharmaceutical Strategies Group an integrated technologyenabled pharmacy solutions and costcontainment company has rebranded its 340B solutions and will be unveiling PSG 340B Link at the 340B Coalition Winter Conference being held i...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Dave Borden's photo - CEO of Pharmaceutical Strategies Group, LLC

CEO

Dave Borden

CEO Approval Rating

85/100

PSG is a provider of benefit consulting and data analytics services to the pharmaceutical sector. Read more